FRANKFURT: BioNTech SE stated on Monday it had began work on a vaccine tailor-made to Omicron, the worrying new coronavirus variant detected in South Africa, although it was not but clear if it must rework its established Covid-19 shot.
The event of an tailored vaccine is a part of the corporate’s customary process for brand new variants, BioNTech, which makes vaccines along with Pfizer, stated in a press release.
“The primary steps of growing a possible new vaccine overlap with the analysis vital with a view to consider whether or not a brand new shot might be wanted,” it added.
The Omicron variant carries a really excessive world danger of surges, the WHO warned on Monday as extra international locations reported circumstances, prompting border closures.
BioNTech had stated on Friday it expects extra lab information over the subsequent two weeks to assist decide if there may be want for an Omicron-specific vaccine. Rival Moderna has stated it was engaged on a redesign of its COVID-19 vaccine for future booster photographs.
The event of an tailored vaccine is a part of the corporate’s customary process for brand new variants, BioNTech, which makes vaccines along with Pfizer, stated in a press release.
“The primary steps of growing a possible new vaccine overlap with the analysis vital with a view to consider whether or not a brand new shot might be wanted,” it added.
The Omicron variant carries a really excessive world danger of surges, the WHO warned on Monday as extra international locations reported circumstances, prompting border closures.
BioNTech had stated on Friday it expects extra lab information over the subsequent two weeks to assist decide if there may be want for an Omicron-specific vaccine. Rival Moderna has stated it was engaged on a redesign of its COVID-19 vaccine for future booster photographs.
Supply: Times of India